BridgeBio’s Neil Kumar on an underdog drug launch and wooing deal-hungry investors
In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and Alnylam.
Cantor Fitzgerald Estimates SPRY FY2025 Earnings
Cantor Fitzgerald issued their FY2025 earnings estimates for ARS Pharmaceuticals in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will ...
Cantor Fitzgerald Estimates Zura Bio FY2025 Earnings
Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Zura Bio in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post ...
The Altamont Enterprise5d
Crisis in Berne is not over, laCour needs our support
The actual crisis began when the ruthless and aggressive Randy Bashwinger totally corrupted the Berne GOP as chairman, and it will not be over until he and his cohort, Mr. [Dennis] Palow, are out of ...
Krone2d
Surprise: Black stronghold loses out
There were many surprises in the district of Mistelbach. Due to the crisis at the regional hospital, however, it was ...